New Releases from NCBI BookshelfPomalidomide with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal).​Pomalidomide with bortezomib and dexamethasone for treating relapsed or refractory multiple myeloma (terminated appraisal).